• Home
  • BSIR IOUK 2025 Annual Meeting

BSIR IOUK 2025 Annual Meeting

Please complete the evaluation below to obtain your certificate of attendance and CPD points.

Please Indicate the days which you attended

Did you attend the Hands On Learning Session? If yes, how helpful did you find it? (please rate 1-5, 1 being lowest, and 5 being highest)

1 2 3 4 5 I did not attend this session
SIRT
TACE
IRE
ECT
Ablation
Cryo-Ablation

If you did not participate in the Hands On Learning Session, session, could you share why this was the case, to help us with planning for future years?

1 2 3 4 5
It was too early and I was travelling
I thought it was optional
I did not think that the content would be relevant to me
I knew that I would be able to talk with industry in the breaks
Other (please specify in the free text at the end of the evaluation))

Please rate how informative you found the HCC Debate Session 1-5 (1 being lowest, and 5 being highest)

1 2 3 4 5 I did not attend this session
Early-stage HCC – Modern ablative techniques
Ablative single session Y90 without MAA
Advanced parenchymal preserving surgical techniques for HCC
New novel TACE using hybrid CT angio
Tumour Board

Please rate how informative you found the Future Liver Remnant Session 1-5 (1 being lowest, and 5 being highest)

1 2 3 4 5 I did not attend this session
Liver venous deprivation – Results from Dragon Trial
Radiation lobectomy - update
Estimation of FLR and functional reserve

Please rate how informative you found the Liver Metastatic Disease Session 1-5 (1 being lowest, and 5 being highest)

1 2 3 4 5 I did not attend this session
Oligometastatic disease Ablation Vs Surgery – Lessons learnt from Collission
MCRC – An update on systemic therapy and disease
Y90 in CRLM– Is there a need for update guidance?
Tumour Board

Please rate how informative you found the Palliative IO for Advanced Cancers Session 1-5 (1 being lowest, and 5 being highest)

1 2 3 4 5 I did not attend this session
Palliative Interventions in Advanced Neck and Thoracic tumors
Soft Tissue Tumours and Sarcomas

Please rate how informative you found the Trainee IO Foundation Session Session 1-5 (1 being lowest, and 5 being highest)

1 2 3 4 5 I did not attend this session
HCC management 101: a clinical walkthrough of the BCLC guidelines
Burn, Freeze, Zap: an overview of modern ablation techniques
A beginner’s guide to TACE: techniques, timing and tips

Please rate how informative you found the Pancreas and Biliary Session 1-5 (1 being lowest, and 5 being highest)

1 2 3 4 5 I did not attend this session
Pancreatic IRE V MR guided SABR: Results of Crossfire trial
Endobiliary RFA for Malignant strictures : An update
Y90 for NET liver metastates
IRE for Gall Bladder tumours: Experience from Indi

Please rate how informative you found the GU/Renal Session 1-5 (1 being lowest, and 5 being highest)

1 2 3 4 5 I did not attend this session
Renal IRE
Renal Cryoablation V MWA

Please rate how informative you found the Endocrine Session 1-5 (1 being lowest, and 5 being highest)

1 2 3 4 5 I did not attend this session
MWA Thyroid Ablation Initial experience
Adrenal Ablation

Please rate how informative you found the Practical IO Session 1-5 (1 being lowest, and 5 being highest)

1 2 3 4 5 I did not attend this session
Pancreatic/biliary case
Liver Case
Lung Case
Bone/Soft Tissue Case
Renal Case

Please rate how informative you found the Industry Sponsored Symposiums 1-5 (1 being lowest, and 5 being highest)

1 2 3 4 5 I did not attend this session
Aquilant Sponsored Symposium - Robotic Ablation of Tumours - A New Era of Precision with Epione®
Industry Sponsored Symposium - Sirtex - Update for SIRT with SIR-Spheres® Y-90 resin microspheres
Industry Sponsored Symposium - Sirtex - Treat the Tumour and Save the Liver with degradable starch TACE: rationale and evidence

Please rate how informative you found the Oral Presentation Session 1-5 (1 being lowest, and 5 being highest)

1 2 3 4 5 I did not attend this session
Effects of Image-guided Ablation of Small Renal Mass in Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis
Irreversible Electroporation of Hepatocellular Carcinomas – a single centre intermediate-term outcome
Patient-Reported and Health Related Quality of Life Outcomes After Percutaneous Renal Cryoablation
Liver venous deprivation vs portal vein embolisation: a single centre experience
Patient experience of participation within the CAIN trial, a phase 1 clinical trial evaluating the effectiveness and safety profile of the HistoSonics Histotripsy System in treating primary solid rena

Please rate how informative you found the Jean Ratcliff Oral Presentation Session 1-5 (1 being lowest, and 5 being highest)

1 2 3 4 5 I did not attend this session
The Use of High Frequency Jet Ventilation (HFJV) in Percutaneous Ablations of Colorectal Liver Metastases
From Experience to Complexity: A Two-Cycle Audit of Liver Tumour Ablation Outcomes with Emphasis on Colorectal Liver Metastases
The prognostic value of Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for liver tumours, including HCC, CRLM, and cholangiocarcinoma after image-guided irreversible electroporation.
A novel approach to treat colorectal liver metastases (CRLM) using combined Irreversible Electroporation (IRE) and Thermal Microwave Ablation (MWA).